Triple-negative breast cancer (TNBC) is an aggressive and highly heterogeneous subtype, characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression (2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.